Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol

Osteoporosis International

Volumn 6, Issue 3, 1996, Pages 213-218

  Riemens, S C ^a,b   Oostdijk, A ^a   Van Doormaal, J J ^a   Thijn, C J P ^a   Drent, G ^a   Piers, D A ^a   Groen, E W J ^a   Meerman, L ^a   Slooff, M J H ^a   Haagsma, E B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b University Hospital   (Netherlands)

Author keywords

Bisphosphonates; Bone density; Liver transplantation; Osteoporosis

Indexed keywords

ALFACALCIDOL; CALCITRIOL; CALCIUM; ETIDRONIC ACID; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE TURNOVER; CALCIUM URINE LEVEL; CLINICAL TRIAL; FEMALE; HIP; HUMAN; HYDROXYPROLINE URINE LEVEL; LIVER TRANSPLANTATION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; VERTEBRA FRACTURE;

ADULT; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CALCIUM; CREATININE; DENSITOMETRY, X-RAY; ETIDRONIC ACID; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; HYDROXYPROLINE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; RADIOIMMUNOASSAY; RETROSPECTIVE STUDIES; SPINAL FRACTURES;

EID: 9344264605     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01622737     Document Type: Article

References (26)

1. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855-61.
2. Bikle DD, Genant HK, Cann C, Recker RR, Halloran BP, Strewler GJ. Bone disease in alcohol abuse. Ann Intern Med 1985; 103:42-8.
3. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987;7:137-42.
4. Stellon AJ, Webb A, Compston JE. Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis. Gut 1988;29:378-84.
5. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy: static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver diseases. Gastroenterology 1989;96:213-21.
6. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990;31:82-7.
7. Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant SC, Riggs BL. Rate of cancellous bone remodelling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 1993;14:819-27.
8. Haagsma EB, Thijn CJP, Post JG, Slooff MJH, Gips CH. Bone disease after orthotopic liver transplantation. J Hepatol 1988;6:94-100.
9. Porayko MK, Wiesner RH, Hay JE, Krom RAF, Beaver S, Schwerman L. Bone disease in liver transplant recipients: incidence, timing, and risk factors. Transplant Proc 1991; 23:1462-5.
10. Arnold JC, Hauser D, Ziegler R, et al. Bone disease after liver transplantation. Transplant Proc 1992;24:2709-10.
11. Eastell R, Rolland Dickson E, Hodgson SF, et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991;14:296-300.
12. Hughes H, Hagen L, Sutton RAL. Liquid-chromatographic determination of 4-hydroxyproline in urine. Clin Chem 1986;32:1002-4.
13. Pak CYC, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 1975;292:497-500.
14. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ. Differential changes in bone mineral density of the appendicutar and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981;67:328-35.
15. McDonald JA, Dunstan CR, Dilworth P, et al. Bone loss after liver transplantation. Hepatology 1991;14:613-9.
16. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:1265-71.
17. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73-9.
18. Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
19. Reid IR, Ibbertson HK. Evidence of decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics. Horm Res 1987;27:200-4.
20. Bikle DD, Gee E, Halloran BP, Ryzen E, Haddad JH. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 1984;74:1966-71.
21. Diamond T, Stiel D, Mason R, et al. Serum vitamin D metabolites are not responsible for low turnover osteoporosis in chronic liver disease. J Clin Endocrinol Metab 1989;69:1234-9.
22. Rabinovitz M, Shapiro J, Lian J, Block GD, Merkel IS, VanThiel DH. Vitamin D and osteocalcin levels in liver transplant recipients. Is osteocalcin a reliable marker of bone turnover in such cases? J Hepatol 1992;16:50-5.
23. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla-protein: a specific marker of bone formation in postraenopausal osteoporosis. Lancet 1984;1:1091-3.
24. Watson RGP, Coulton L, Kanis JA, et al. Circulating osteocalcin in primary biliary cirrhosis following liver transplantation and during treatment with cyclosporin. J Hepatol 1990;11:354-8.
25. Kelly PJ, Sambrook PN, Eisman JA. Potential protection by cyclosporin against glucocorticoid effects on bone. Lancet 1989;2:1388.
26. Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA. 1,25-Dihydroxyvitamin D-responsive clement and glucocorticoid repression in the osteocalcin gene. Science 1989;246:1158-61